Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

etrials Inc.

This article was originally published in Start Up

Executive Summary

A little younger than some of its competitors in the electronic data capture world, etrials Inc. has nonetheless made a name for itself since its 1999 founding. Revenues are up, its list of customers is growing and the European marketing is beckoning for its integrated suite of products designed to streamline clinical trials for biotech and Pharma clients.

You may also be interested in...



In Vivo's Deals Of The Month, February 2018

In Vivo's editors pick January's most significant deals, including Roche's acquisition of Flatiron and Moderna's latest big private fundraising. (Free article.)

In Vivo's Deals Of The Month, January 2018

In Vivo's editors pick January's most significant deals, including an alliance of players new to health care and Celgene's big buys. (Free article.)

In Vivo's 2017 Deals Of The Year: The Winners Are…

We nominated 15 deals in three categories. You picked the winners.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC090621

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel